119 related articles for article (PubMed ID: 12133519)
1. [Relationship between angiotensin-1 converting enzyme gene polymorphism and in-stent restenosis].
Qu X; Zhao J; Liu P; Song L; Zhao K; Liu H; Huang Y
Zhonghua Yi Xue Za Zhi; 2002 Apr; 82(7):474-6. PubMed ID: 12133519
[TBL] [Abstract][Full Text] [Related]
2. Association study of the I/D polymorphism and plasma angiotensin-converting enzyme (ACE) as risk factors for stent restenosis.
Ribichini F; Ferrero V; Matullo G; Feola M; Vado A; Camilla T; Guarrera S; Carturan S; Vassanelli C; Uslenghi E; Piazza A
Clin Sci (Lond); 2004 Oct; 107(4):381-9. PubMed ID: 15101817
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin-converting enzyme insertion/deletion polymorphism does not influence the restenosis rate after coronary stent implantation.
Ferrari M; Mudra H; Grip L; Voudris V; Schächinger V; de Jaegere P; Rieber J; Hausmann D; Rothman M; Koschyk DH; Figulla HR;
Cardiology; 2002; 97(1):29-36. PubMed ID: 11893827
[TBL] [Abstract][Full Text] [Related]
4. Predictors of coronary in-stent restenosis: importance of angiotensin-converting enzyme gene polymorphism and treatment with angiotensin-converting enzyme inhibitors.
Jørgensen E; Kelbaek H; Helqvist S; Jensen GV; Saunamäki K; Kastrup J; Havndrup O; Bundgaard H; Kyst Madsen J; Christiansen M; Andersen PS; Reiber JH
J Am Coll Cardiol; 2001 Nov; 38(5):1434-9. PubMed ID: 11691520
[TBL] [Abstract][Full Text] [Related]
5. Association of ACE gene polymorphisms with in-stent restenosis by stent type (biomime, supraflex, xience).
Klashami ZN; Roudbordeh MG; Asadi M; Ebrahimi P; Amoli MM
Mol Biol Rep; 2023 Aug; 50(8):6445-6455. PubMed ID: 37328581
[TBL] [Abstract][Full Text] [Related]
6. Relationship of the rs1799752 polymorphism of the angiotensin-converting enzyme gene and the rs699 polymorphism of the angiotensinogen gene to the process of in-stent restenosis in a population of Polish patients with stable coronary artery disease.
Osadnik T; Strzelczyk JK; Fronczek M; Bujak K; Reguła R; Gonera M; Gawlita M; Kurek A; Wasilewski J; Lekston A; Gierlotka M; Hawranek M; Ostrowska Z; Wiczkowski A; Poloński L; Gąsior M
Adv Med Sci; 2016 Sep; 61(2):276-281. PubMed ID: 27162064
[TBL] [Abstract][Full Text] [Related]
7. The relationship between angiotensin converting enzyme gene polymorphism, coronary artery disease, and stent restenosis: the role of angiotensin converting enzyme inhibitors in stent restenosis in patients with diabetes mellitus.
Guneri S; Baris N; Aytekin D; Akdeniz B; Pekel N; Bozdemir V
Int Heart J; 2005 Sep; 46(5):889-97. PubMed ID: 16272779
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin I-converting enzyme (ACE) inhibitors and restenosis after coronary artery stenting in patients with the DD genotype of the ACE gene.
Koch W; Mehilli J; von Beckerath N; Böttiger C; Schömig A; Kastrati A
J Am Coll Cardiol; 2003 Jun; 41(11):1957-61. PubMed ID: 12798565
[TBL] [Abstract][Full Text] [Related]
9. Renin-angiotensin-aldosterone system (RAAS) gene polymorphism as a risk factor of coronary in-stent restenosis.
Ryu SK; Cho EY; Park HY; Im EK; Jang YS; Shin GJ; Shim WH; Cho SY
Yonsei Med J; 2002 Aug; 43(4):461-72. PubMed ID: 12205735
[TBL] [Abstract][Full Text] [Related]
10. Quinapril prevents restenosis after coronary stenting in patients with angiotensin-converting enzyme D allele.
Okumura K; Sone T; Kondo J; Tsuboi H; Mukawa H; Tsuzuki M; Imai H; Kamiya H; Mabuchi Y; Matsui H; Hayakawa T
Circ J; 2002 Apr; 66(4):311-6. PubMed ID: 11954942
[TBL] [Abstract][Full Text] [Related]
11. D allele of the angiotensin I-converting enzyme is a major risk factor for restenosis after coronary stenting.
Amant C; Bauters C; Bodart JC; Lablanche JM; Grollier G; Danchin N; Hamon M; Richard F; Helbecque N; McFadden EP; Amouyel P; Bertrand ME
Circulation; 1997 Jul; 96(1):56-60. PubMed ID: 9236417
[TBL] [Abstract][Full Text] [Related]
12. Insertion/deletion polymorphism of the angiotensin I-converting enzyme gene is not associated with restenosis after coronary stent placement.
Koch W; Kastrati A; Mehilli J; Böttiger C; von Beckerath N; Schömig A
Circulation; 2000 Jul; 102(2):197-202. PubMed ID: 10889131
[TBL] [Abstract][Full Text] [Related]
13. Influence of angiotensin converting enzyme insertion/deletion polymorphism on long-term total graft occlusion after coronary artery bypass surgery.
Dayi SU; Tartan Z; Terzi S; Kasikcioglu H; Uyarel H; Orhan G; Alper AT; Ciloglu F; Cam N
Heart Surg Forum; 2005; 8(5):E373-7. PubMed ID: 16146835
[TBL] [Abstract][Full Text] [Related]
14. Recurrent in-stent restenosis is not associated with the angiotensin-converting enzyme D/I, angiotensinogen Thr174Met and Met235Thr, and the angiotensin-II receptor 1 A1166C polymorphism.
Gross CM; Perrot A; Geier C; Posch MG; Hassfeld S; Kramer J; Schmidt S; Derer W; Dietz R; Ozcelik C
J Invasive Cardiol; 2007 Jun; 19(6):261-4. PubMed ID: 17541127
[TBL] [Abstract][Full Text] [Related]
15. Relationship of interleukin-6-572C/G promoter polymorphism and serum levels to post-percutaneous coronary intervention restenosis.
Gao J; Liu Y; Cui RZ; Mao YM; Zhou J; Chen Q; Zhao FM; Yang GM
Chin Med J (Engl); 2013 Mar; 126(6):1019-25. PubMed ID: 23506572
[TBL] [Abstract][Full Text] [Related]
16. [D/D genotype of the gene for angiotensin converting enzyme as a risk factor for post-stent coronary restenosis].
Guarda E; Fajuri A; Marchant E; Martínez A; Jalil J; Illanes G; Vecchiola A; Lazen R; Flores A; Barra V; Irarrázabal S; Ilabaca F
Rev Esp Cardiol; 1999 Jul; 52(7):475-80. PubMed ID: 10439670
[TBL] [Abstract][Full Text] [Related]
17. Relation between the insertion/deletion polymorphism of the angiotensin I converting enzyme gene and restenosis after coronary stenting.
Gürlek A; Güleç S; Karabulut H; Bokesoy I; Tutar E; Pamir G; Alpman A; Toydemir R; Aras O; Oral D
J Cardiovasc Risk; 2000 Dec; 7(6):403-7. PubMed ID: 11155292
[TBL] [Abstract][Full Text] [Related]
18. The DD genotype of angiotensin converting enzyme polymorphism is a risk factor for coronary artery disease and coronary stent restenosis in Japanese patients.
Taniguchi I; Yamazaki T; Wagatsuma K; Kurusu T; Shimazu Y; Takikawa K; Yoshikawa M; Kageyama S; Mochizuki S
Jpn Circ J; 2001 Oct; 65(10):897-900. PubMed ID: 11665795
[TBL] [Abstract][Full Text] [Related]
19. Plasma activity and insertion/deletion polymorphism of angiotensin I-converting enzyme: a major risk factor and a marker of risk for coronary stent restenosis.
Ribichini F; Steffenino G; Dellavalle A; Matullo G; Colajanni E; Camilla T; Vado A; Benetton G; Uslenghi E; Piazza A
Circulation; 1998 Jan; 97(2):147-54. PubMed ID: 9445166
[TBL] [Abstract][Full Text] [Related]
20. Effect of ACE inhibitors on angiographic restenosis after coronary stenting (PARIS): a randomised, double-blind, placebo-controlled trial.
Meurice T; Bauters C; Hermant X; Codron V; VanBelle E; Mc Fadden EP; Lablanche J; Bertrand ME; Amouyel P
Lancet; 2001 Apr; 357(9265):1321-4. PubMed ID: 11343737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
